.png){kind=icon}
Return
Raltegravir
.png){kind=icon}
PRE
AI
DOI：10.1038/nrd2512.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
INTEGRASE INHIBITOR RALTEGRAVIR
REPLICATION
SUPPRESSION
THERAPY
VIRUS
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
Cited Papers
ShareSaveDisease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response.png)
AIDS
OAAI
AIDSIF3.1
OAAIShareSaveSafety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trialLANCET
LANCETIF88.5
PREAI
ShareSaveShareSaveShareSave no more
no more